SOW
RIGL icon

State of Wyoming’s Rigel Pharmaceuticals RIGL Stock Holding History

State of Wyoming’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.22K Sell
304
-117
-28% -$3.93K ﹤0.01% 1729
2025
Q4 		$18K Buy
+421
New +$15.9K ﹤0.01% 1698
2024
Q3 		– Sell
-11,029
Closed -$90.7K – 1867
2024
Q2 		$90.7K Buy
11,029
+2,097
+23% +$21.9K 0.01% 1068
2024
Q1 		$132K Sell
8,932
-2,300
-20% -$31K 0.02% 835
2023
Q4 		$163K Buy
11,232
+2,613
+30% +$26.7K 0.03% 699
2023
Q3 		$93.1K Buy
8,619
+2,073
+32% +$24.9K 0.02% 906
2023
Q2 		$84.4K Buy
6,546
+4,700
+255% +$63.5K 0.02% 927
2023
Q1 		$24.4K Sell
1,846
-370
-17% -$5.88K 0.01% 1375
2022
Q4 		$33.2K Buy
+2,216
New +$20.3K 0.01% 1187
2022
Q3 		– Sell
-798
Closed -$9K – 1870
2022
Q2 		$9K Sell
798
-245
-23% -$4.92K 0.01% 1661
2022
Q1 		$31K Buy
1,043
+144
+16% +$3.9K 0.02% 1302
2021
Q4 		$24K Buy
899
+500
+125% +$15.1K 0.01% 1426
2021
Q3 		$14K Buy
399
+224
+128% +$8.82K 0.01% 986
2021
Q2 		$8K Buy
+175
New +$6.61K 0.01% 1039

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State of Wyoming's RIGL Position: Q1 2026 in Review

State of Wyoming reduced its Rigel Pharmaceuticals (RIGL) stake by 28% in Q1 2026, selling an estimated $3.93K and leaving 304 shares worth $8.22K. The position accounts for ﹤0.01% of the portfolio, ranked #1729.

State of Wyoming first reported a position in RIGL in Q2 2021 and has held it in 14 quarters since. The position peaked at $163K in Q4 2023. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • State of Wyoming held 304 shares of Rigel Pharmaceuticals worth $8.22K as of Q1 2026.
  • State of Wyoming sold 117 Rigel Pharmaceuticals shares in Q1 2026, an estimated $3.93K.
  • Rigel Pharmaceuticals made up ﹤0.01% of State of Wyoming's portfolio in Q1 2026, its #1729 holding.
  • State of Wyoming first reported a position in Rigel Pharmaceuticals in Q2 2021 and has held it in 14 quarters since.
  • State of Wyoming's Rigel Pharmaceuticals position peaked at $163K in Q4 2023.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.